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Abstract 
Pediatric chronic pain is associated with numerous negative outcomes including increased physical 
disability, increased rates of depression and anxiety, and decreased quality of life. Pain catastrophizing – 
broadly conceptualized as including rumination, magnification, and helplessness cognitions surrounding one’s 
pain – has been linked with poor functional outcomes in children with chronic pain. Pain catastrophizing in 
pediatric chronic pain is often considered a key factor on which to focus treatment efforts. However, absent a 
systematic review that integrates the relevant literature, this call for routine assessment and targeted treatment 
may be premature. The present study aimed to: 1) meta-analytically quantify the relationship between 
catastrophizing and pain and functional/psychosocial outcomes (functional disability/physical functioning, 
anxiety, depression, and quality of life) in children with chronic pain, and 2) examine potential moderators of 
these relationships. Using a random effects model, a total of 111 effect sizes from 38 studies were analyzed. 
Effect sizes ranged from medium to large, with anxiety, depression, and quality of life demonstrating a strong 
association with catastrophizing. Pain intensity and physical disability had a moderate association with 
catastrophizing. These relationships were robust, minimizing potential publication bias. None of the examined 
moderators were significant. The strong relationships found between catastrophizing and anxiety, depression, 
and quality of life suggest that successfully intervening on catastrophizing could have far reaching implications 
in improving pain outcomes in pediatric chronic pain. 
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Introduction 
Chronic pain is associated with negative outcomes in children and adolescents, including worse physical 
and emotional functioning [5,9,33,50,53,54,66,75,81,83,100]. Many factors have been explored to determine 
why chronic pain leads to such poor outcomes. Pain catastrophizing is one such factor [19,104]. As detailed by 
Turner and Aaron (2001), catastrophizing is historically rooted in the broader psychological literature and is 
most commonly linked with anxiety disorders [12,102] and depression [32]. Nearly two decades after what 
many consider to be the first use of the term by Albert Ellis [20], scholars began characterizing and examining 
the impact of catastrophizing about pain specifically [13,14,89,101]. Several of the early self-report measures of 
pain-related coping, such as the Cognitive Error Questionnaire (CEQ) [63] and the Coping Strategies 
Questionnaire (CSQ) [89], included items assessing catastrophic thinking about pain. However, the content of 
these items differ across measures. Many of the items from the CEQ assess pessimistic pain-related thoughts 
about the future (e.g., “If I don’t get some time to relax during the day, I’m going to be bedridden and unable to 
work.”), whereas items from the CSQ focus solely on helplessness cognitions (e.g., “I feel like I can’t go on.”). 
Over ten years later, in an effort to integrate the various theories and measurements of pain catastrophizing, 
Sullivan and colleagues (1995) created the Pain Catastrophizing Scale [104], which includes three separate but 
related domains: rumination, magnification, and helplessness. Although the work of Sullivan and colleagues 
mark a turning point in our understanding of pain catastrophizing (at least as indicated by the exponential 
growth in the literature and the predominance of the PCS as the gold standard measure), Turner and Aaron 
(2001) argue that none of the currently available measures, including the PCS, fully capture the construct of 
catastrophizing as defined in the broader field of psychology. Specifically, they contend that none tap into 
thoughts about the worse possible outcomes of pain (e.g., paralysis, complete disability), although they do 
acknowledge that the CEQ comes closest. Given these historical developments, and the fact that the three-factor 
model is privileged in most of the contemporary work in this area, we adopted Sullivan and colleagues’ [104] 
conceptualization of pain catastrophizing for the current systematic review. 
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The aforementioned developments focused exclusively on adults with pain. Nearly a decade later, the 
pediatric literature began examining the impact of catastrophizing in pediatric pain experience. Self-report 
measures assessing pain catastrophizing in children and adolescents were created de novo (e.g., Pain Response 
Inventory [121] & Pain Coping Questionnaire [88]) or adapted from existing adult versions (e.g., CSQ – Child 
version [35], & PCS – Child version [19]). Research using these measures has found that catastrophizing in 
children with chronic pain is linked to greater pain and disability (cross-sectionally and longitudinally) [8,19], 
and to increased pain behaviors [74] and analgesic use [7]. In addition, previous research found that high 
catastrophizing children had significantly worse psychological outcomes than low catastrophizing children [21], 
with high catastrophizers scoring 4 times higher on a measure of depressive symptoms than their counterparts 
[74].  
On account of these advancements in the theory and measurement of pain catastrophizing, along with 
the seemingly consistent pattern of findings suggesting that catastrophizing contributes to negative pain 
outcomes for children, several scholars have called for routine assessment of pain catastrophizing in pediatric 
chronic pain and consider it a key factor on which to focus treatment efforts [1,55,127]. However, this call for 
routine assessment and targeted treatment may be premature. To date, no study has systematically integrated the 
previous results, quantified the magnitude of the relationship between catastrophizing and poor pain outcomes 
in children, or explored possible moderating factors. Such information is critical for healthcare providers and 
administrators to best allocate finite clinical and financial resources to the patients that are most in need.  
Given the rapid developmental changes – physical and psychosocial – that take place during childhood 
and adolescence, several moderators should be examined in the context of catastrophizing and its relation to 
poor outcomes in pediatric chronic pain. Age is one such moderator. Research suggests that increased age is 
associated with increased levels of catastrophizing [7]; thus, the strength of the relationships between 
catastrophizing and pain outcomes may vary with age. Gender may also moderate the relationship between 
catastrophizing and pain outcomes. Socialization in relation to pain differs for girls and boys. In both healthy 
and chronic pain samples, pain catastrophizing is associated with higher levels of pain expression [116,117]. 
This is potentially important in the context of gender differences given that girls display more pain behaviors 
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4than boys, which may result in girls receiving more comfort from others when in pain [28]. This differential 
reinforcement may, in turn, contribute to gender differences in catastrophizing and pain outcomes.  
In addition to developmental factors that may affect the relationship between catastrophizing and pain 
outcomes, there are several other factors to consider. Pain severity may influence the relationship between 
catastrophizing and pain outcomes, given that increasing levels of pain are related to higher levels of 
catastrophizing [94,108]. Pain duration may also influence this relationship. A longer pain duration may 
exacerbate catastrophic and helpless perceptions (i.e., “It’s never going to get any better”), or it may attenuate 
them (i.e., “I need to accept this pain”). Another clinical factor to consider is type of chronic pain. Research 
suggests that levels of catastrophizing differ by pain diagnosis. For example, several studies have found that 
sickle cell patients have higher levels of pain catastrophizing than those with rheumatoid arthritis or 
musculoskeletal pain [16,47]. In addition to developmental and clinical factors, the specific measure used to 
assess catastrophizing may affect its relationship to pain. Measures of catastrophizing vary across clinical and 
research settings. These measures have different conceptualizations (unidimensional versus multidimensional) 
of catastrophizing and consequently, different psychometric properties. These differences between measures 
may influence the association between catastrophizing and pain outcomes.  
In summary, catastrophizing is commonly touted as a key clinical construct to measure and focus 
treatment efforts on in the pediatric pain context. However, no systematic review has been conducted to 
integrate the relevant literature and guide these clinical efforts. Filling this knowledge gap would enhance 
treatment and guide allocation of resources to the patients who would benefit from treatment most. Thus, the 
aims of this study were to: 1) meta-analytically quantify the relationship between catastrophizing and pain and 
functional/psychosocial outcomes (physical functioning, anxiety, depression, and quality of life) in children 
with chronic pain, and 2) examine age, gender, pain intensity, pain duration, pain diagnosis, and measure type 
as moderators of these relationships. 
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Methods 
Literature Search 
Empirical studies were identified using PsychInfo, Medline, PubMed, and Embase databases. Relevant 
articles published through March 23, 2017 were selected based on searches defined by all possible keyword 
combinations of terms for 1) catastroph*, 2) child*, youth, adoles*, and 3) pain, chronic pain, nociception. 
Electronic mail alerts were created using these terms to identify articles published after the initial search. 
Reference sections of identified empirical studies were reviewed for additional relevant studies. In addition, 
forward searches were conducted using identified articles to find additional relevant articles. Study authors were 
contacted for any necessary information needed for analyses from studies that reported insufficient information 
(see Table 1). 
Inclusion and Exclusion Criteria 
Studies were included if they 1) had measures of child-reported catastrophizing and one or more of the 
following: pain intensity, physical functioning, depression, anxiety, or quality of life (QOL), 2) were based on 
an independent child or adolescent sample (between the ages of 8 and 21) with chronic pain (i.e., persistent pain 
for 3 or more months), and 3) were available in English. Also, the studies needed to provide an effect size or 
contain information that allowed calculation of an effect size representing the relationship between 
catastrophizing and one or more of the pain outcomes of interest. Only effect sizes representing the relationship 
between baseline, or pre-intervention, levels of catastrophizing and functional/psychosocial outcomes were 
included. 
Coding of Studies  
Each article was read and coded independently by two study authors (M.M.M. and S.M.M.) using a 
standardized coding form.  
Basic study information and study variables. Sample-level information included publication year and 
type of publication. Sample characteristics included total sample size, race (percent White), gender (percent 
female), mean age, and whether or not the sample included participants over 18 years of age. 
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Moderator coding. Gender (percent female), mean age of sample, mean pain intensity rating, and 
mean pain duration (in months) were coded as continuous moderators. Type of chronic pain and catastrophizing 
measure were coded as categorical moderators. 
Quality Assessment 
 Studies were assessed for common sources of bias in observational studies [41,91]. Many items on the 
typical quality rubrics used for meta-analyses are not relevant for correlational designs [44,79]. Thus, for the 
current study, we used a modified version of the rubric from Salyers and colleagues’ [90] meta-analysis, such 
that study quality ratings ranged from 0 to 10. The initial rating system was tested and refined on several studies 
before applying it to the full sample of studies. Interrater reliability of the initial codes was strong (r=.81, 
p<.01), and disagreements were resolved through discussion.  
 
Meta-Analytic Method 
 Mean Effect Size. Pearson’s r was used as the effect size statistic for the relationship between 
catastrophizing and the pain outcomes of interest. Effect sizes were coded such that higher values reflect higher 
levels of catastrophizing and greater pain intensity, poorer physical functioning, higher levels of anxiety 
symptoms, higher levels of depressive symptoms, and worse QOL. All effect sizes were corrected using 
Fisher’s r-to-Z transformation, which mitigates the problematic standard error formulation inherent in using r in 
its raw form. Effect sizes at the study level were weighted by sample size in order to account for the standard 
error in effect size estimates [11]. When a study provided multiple values for an association, an average effect 
size was calculated to reduce bias [11].  
A random effects model was used, when appropriate (k ≥ 6), due to effects of both within-study and 
between-study variability [65]; when k < 6, the fixed effects model is reported. Effect sizes, mean effect sizes, 
and moderation models were calculated using IBM SPSS Statistics 24 and macros provided by Wilson (2017) 
[126]. Effect sizes were transformed back to r for ease of interpretation using the inverse of the Fisher’s r-to-z 
transformation. Correlation coefficients of less than 0.10 were considered small, correlations of 0.25 were 
considered medium, and correlations greater than or equal to 0.40 were considered large [65].  
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Heterogeneity for each overall effect size was examined using the Q-statistic [11], with significant 
results (p < .10) suggesting moderation [45]. The I2 index was calculated to examine the extent of heterogeneity 
[45]. When I2 values were greater than or equal to 25%, moderator analyses were conducted [49], as this 
suggests that between-study variability in effect sizes exceeds levels that would be expected by chance [49].  
A fail-safe N analysis was conducted to estimate how many studies with null findings would be 
necessary to reduce the effect sizes to non-significance [80]. Q-test effect size comparisons (with follow-up z 
tests) were conducted to determine the largest effect size for each outcome. The influence of publication bias 
was evaluated using Egger’s regression approach and funnel plots [23]. 
Moderation Analyses. Categorical moderators were tested using Q statistics and I2 indices (polarized 
effect sizes, decreased I2, and small confidence interval ranges indicating moderation), and continuous 
moderators were assessed for significant beta weights and decreased I2 using meta-regressions [49]. Because 
meta-regressions use list-wise deletion, each moderator was examined independently in order to maximize the 
number of studies included in the analysis. A minimum of two studies per comparison group for categorical 
moderators was considered necessary for conducting planned meta-analyses. 
For the first aim, the mean effect sizes between catastrophizing and pain, physical functioning, anxiety, 
depression, and QOL were calculated. For the second aim, categorical and continuous moderators were 
explored when heterogeneity indexes indicated potential moderation.  
Subgroup Analyses. In an effort to be inclusive, studies that included participants over the age of 18 or 
a small subset of participants reporting pain for < 3 months were included. Differences in mean effect size 
based on inclusion or exclusion of these samples were explored in subgroup analyses.  
Results 
Study Sample 
 One thousand two hundred and eighty-two records were identified through the initial database search. 
Sixty five studies met inclusion criteria. Of these 65 studies, 36 did not report sufficient effect size information. 
All corresponding authors were contacted via email to obtain required information. Twelve authors provided the 
necessary information and these data were included in the final sample, resulting in 38 unique samples of 
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children with chronic pain (see Figure 1 for PRISMA flow diagram). Two studies were included that 
overlapped with other study samples but reported a unique catastrophizing – pain outcome relationship and so 
were retained for analysis. Descriptions of these 2 studies were omitted in the study summary (Table 1) and 
study quality (Table 2) tables to avoid duplication.  
 A total of 111 effect sizes from 38 studies were included in the final sample. Each study provided an 
average of 2.5 effect sizes. Studies used the following self-report measures of pain catastrophizing: Pain 
Catastrophizing Scale – Child (PCS-C) and adult report (PCS), Pain Coping Questionnaire (PCQ), Coping 
Strategies Questionnaire – Child (CSQ-C), Pain Response Inventory (PRI), and Pain-related Cognitions 
Questionnaire (PRCQ). The most commonly used measures were PCS-C (k=23), PCQ (k=8), and PCS (k=5). 
 The overall sample size contained 6202 participants, with the mean sample size for included studies 
equal to 77 participants. Study samples were, on average, predominately female (M=72%) and White 
(M=80%). The mean age for the samples was 14.4 years (range: 11.2-18.3). Three studies provided multiple 
effect sizes for one of the catastrophizing-pain outcome relationships; these effect sizes were averaged within 
each study for subsequent analyses. Additional study summary characteristics are reported in Table 1. 
Relationship between Catastrophizing and Pain Outcomes 
 Table 3 presents the original and corrected (Fisher’s r-to-Z transformed) effect sizes and sample level 
information for studies included in the final meta-analysis.  
Pain intensity. The meta-analysis of the relationship between catastrophizing and pain intensity 
included 35 independent samples and resulted in a positive medium effect size, with r=0.29 (95% CI: 0.24 – 
0.34, Table 4). The overall effect was significantly different from zero (z=11.37, p<0.01). Orwin’s fail safe N 
analysis indicated an additional 172 studies with null effects would be needed to reduce the overall mean effect 
to non-significance. Egger’s regression test of asymmetry resulted in a precision value = -0.17 (90% CI: -1.37 to 
1.04, p=0.78), indicating no significant amount of asymmetry and suggesting no significant amount of 
publication bias [23]. The funnel plot indicates a roughly symmetric distribution of effect sizes, with most of the 
effects around the mean intercept, further suggesting that publication bias is unlikely (Figure 2). The Q-statistic 
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of the overall effect was 85.12, with a substantial amount of heterogeneity (I2=60.06%) warranting additional 
moderation analyses. 
Physical functioning. The meta-analysis of the relationship between catastrophizing and physical 
functioning included 30 independent samples and resulted in a positive medium effect size, with r=0.39 (95% 
CI: 0.35 – 0.43, Table 4). The overall effect was significantly different from zero (z=15.26, p<0.01), and an 
additional 210 studies with null effects would be needed to reduce this to non-significance. Egger’s regression 
test of asymmetry resulted in a precision value = -0.17 (90% CI: -1.44 to 1.09, p=0.78), indicating no significant 
amount of asymmetry and minimal publication bias (Egger et al., 1997). The funnel plot was roughly 
symmetrical, further suggesting that publication bias is unlikely (Figure 3). The results of heterogeneity 
analyses (Q=72.33, I2=59.91%) supported additional moderation analyses. 
Anxiety. The meta-analysis of the relationship between catastrophizing and anxiety included 15 
independent samples and resulted in a positive large effect size, with r=0.55 (95% CI: 0.50 – 0.59, Table 4). 
The overall effect was significantly different from zero (z=18.96, p<0.01). Orwin’s fail safe N analysis 
indicated an additional 165 studies with null effects would be needed to reduce the overall mean effect to non-
significance. Egger’s regression test of asymmetry resulted in a precision value = 0.37 (90% CI: -1.00 to 1.73, 
p=0.57), indicating no significant amount of asymmetry and minimal publication bias [23]. The funnel plot was 
roughly symmetrical, further suggesting that publication bias is unlikely (Figure 4). The Q-statistic of the 
overall effect was 28.04, with a moderate amount of heterogeneity (I2=45.91%).  
Depression. The meta-analysis of the relationship between catastrophizing and depression included 19 
independent samples and resulted in a positive large effect size, with r=0.49 (95% CI: 0.43 – 0.55, Table 4). 
The overall effect was significantly different from zero (z=12.58, p<0.01) and an additional 180 studies with 
null effects would be needed to reduce this to non-significance. Egger’s regression test of asymmetry resulted in 
a precision value = 0.49 (90% CI: -1.48 to 2.46, p=0.61), indicating no significant amount of asymmetry, 
suggesting no significant amount of publication bias [23]. The funnel plot indicates a roughly symmetric 
distribution of effect sizes (Figure 5). The results of heterogeneity analyses (Q=66.96, I2=73.12%) supported 
additional moderation analyses.  
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Quality of life. The meta-analysis of the relationship between catastrophizing and QOL included 10 
independent samples and resulted in a positive large effect size, with r= -0.48 (95% CI: -0.56 – -0.39, Table 4). 
The overall effect was significantly different from zero (z=9.32, p<.01) with fail safe N analysis indicated 91 
additional studies with null effects would be needed to reduce the overall mean effect to non-significance. 
Egger’s regression test of asymmetry resulted in a precision value = 0.37 (90% CI: -2.10 to 2.84, p=0.74), 
indicating no significant amount of asymmetry, suggesting no significant amount of publication bias [23]. The 
funnel plot indicates a roughly symmetric distribution of effect sizes, further suggesting that publication bias is 
unlikely (Figure 6). The Q-statistic of the overall effect was 30.31, with a substantial amount of heterogeneity 
(I2=70.31 %), indicating the need for additional moderation analyses.  
Moderation 
 Moderator analyses for the relationship between catastrophizing, pain, and pain outcomes are shown in 
Tables 5 - 7. Among the continuous moderators and contrary to hypotheses, gender, age, pain intensity, and 
pain duration did not significantly moderate the relationship between catastrophizing and any of the pain 
outcomes. Similarly, among the categorical moderators, neither type of chronic pain nor catastrophizing 
measure significantly moderated (p>.05 for Q(b) values) any of the relationships between catastrophizing and 
pain outcomes. We could not conduct categorical moderation analyses of the relationship between 
catastrophizing and QOL due to having less than 2 studies for pain diagnosis or catastrophizing measure 
subgroups. 
Study Quality 
 Study quality is reported in Table 2. The mean QR for studies was 5.97 (Median=6, Mode=5). In line 
with previous studies [17,27,48,90], quality rating (QR) was examined as a moderator of subgroup differences 
in effect sizes. Studies were grouped using sample mode (5) as a cut point [90], with studies 6 or above coded 
as “higher quality” and studies scoring at or below 5 considered “lower quality”. Effect sizes between these two 
groups were compared. Study quality was not a significant moderator (p>0.05 for Q(b) values) for any of the 
relationships between catastrophizing and pain outcomes. Detailed results are presented in Table 8. 
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Sub-group Analyses 
 Two study characteristics were explored to assess their impact on the mean effect size: (1) whether or 
not samples included any participants older than 18 years of age, and (2) whether or not samples contained any 
participants reporting pain duration less than 3 months. Mean ESs were estimated including and excluding 
studies with these characteristics (i.e., participants older than 18 and participants with pain <3 months). As seen 
in Table 9, minimal differences in mean effect sizes were observed between the total study sample and the 
subgroups, indicating that these study characteristics did not substantially influence the results. 
 
Discussion 
 The current meta-analysis assessed the magnitude of the relationship between catastrophizing, pain, and 
functional outcomes in children with chronic pain. Effect sizes ranged from medium to large, with anxiety, 
depression, and QOL demonstrating strong associations with catastrophizing. Pain intensity and physical 
functioning had moderate associations with catastrophizing. These relationships were robust, minimizing the 
potential influence of publication bias and study quality. Gender, age, pain intensity rating, pain duration, pain 
diagnosis, and type of catastrophizing measure did not significantly moderate the relationship between 
catastrophizing and pain or functional/psychosocial outcomes.  
Of the outcomes examined in the current meta-analysis, anxiety and depression had the strongest 
absolute relationships with catastrophizing. This strong relationship may be partially due to individuals having a 
general maladaptive thinking style that transcends pain-related stressors. Both in a broader psychological 
context and specifically within the chronic pain literature, catastrophizing has been characterized as a 
maladaptive thinking style in response to stress [6,24,104], frequently observed among individuals with anxiety 
[12,102] and depressive disorders [32], as well as those with chronic pain [87]. Thus, children who 
catastrophize in response to pain – and/or who appraise pain in catastrophic ways – may do similarly for non-
pain stressors. This general cognitive-emotional style may explain the strong relationships between 
catastrophizing and anxiety and depression observed herein. Worth noting, a handful of studies point to 
conceptual overlap as a reason for the strong association between pain catastrophizing and negative mood (e.g., 
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depression, anxiety) [1,46,105]. Although we acknowledge these blurry demarcations, cross-sectional 
[34,58,106] and longitudinal [57] evidence supports the conceptual distinctiveness of pain catastrophizing. 
These conceptual issues are paralleled by concerns about measurement overlap and common-method variance. 
Subscale or item level analysis between measures of catastrophizing, anxiety, and depression may clarify the 
relevance of these methodological issues. Unfortunately, because the majority of studies included in the current 
meta-analysis did not report subscale or item level scores, we could not undertake such analyses ourselves.  
The strong relationship between catastrophizing and emotional outcomes suggests that intervention 
efforts aimed at decreasing catastrophic thinking may reduce anxiety and depressive symptoms among children 
with pain. Only a few studies have examined this issue. Kashikar-Zuck and colleagues [56] evaluated an 8-week 
CBT program for children with Juvenile Fibromyalgia and found that while catastrophizing decreased over the 
course of treatment, it did not mediate improvement in depressive symptoms. Similarly, Wicksell and 
colleagues [124] found that catastrophizing did not mediate changes in depression in response to an Acceptance 
and Commitment Therapy program (ranging from 7 to 20 therapy sessions) for pediatric chronic pain. Although 
these studies suggest that cognitive-behavioral and acceptance-based approaches can effectively reduce pain 
catastrophizing in children, much remains to be known about whether and how these changes translate into 
improvement in psychological functioning. Of note, these studies used less common measures of 
catastrophizing (PRI and PCQ), and neither assessed anxiety symptoms, thus constraining our understanding of 
these relationships.  
Catastrophizing and physical functioning were moderately related in our analysis. The fear-avoidance 
model (FAM) of chronic pain provides one lens through which to interpret this relationship [3,62,85,97]. The 
FAM posits that poor physical functioning results from pain-related catastrophizing and threat appraisals. 
Thinking about pain in this way increases fear of future pain, leading to avoidance of activities and ultimately to 
disuse and disability [97]. This model has been applied to pediatric populations, lending support to the idea that 
intervening on pain catastrophizing could lead to improved physical functioning in children and adolescents 
with pain through decreases in their fear of pain and avoidance of activities. The biopsychomotor model offers 
another perspective on the connection between catastrophizing and physical functioning in children and 
AC
CE
PT
ED
Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            201
 13 
adolescents. This model posits that pain behavior is an integral part of the pain system [103], serving 
communicative, protective, and social-relational purposes. Pain expression is a form of communication, 
transmitting information that has survival value while also soliciting attention and support for the pain sufferer 
[36,40,125]. Although catastrophizing has been linked to increased communicative pain behaviors, specifically 
facial expressions of pain [72,117,118], the protective and social-relational aspects of the biopsychomotor 
model seem particularly relevant to the current findings regarding the link between catastrophizing and physical 
functioning. Children who endorse high levels of catastrophizing about their pain may, consequently, engage in 
protective behaviors (e.g., guarding, bracing) that have been linked to increased functional disability [107]. 
These behaviors may also trigger the social response system of proximal others, leading to solicitous behaviors 
from parents, teachers, and peers. Such solicitousness may reinforce the child’s pain and avoidance behaviors 
thereby leading to continued physical disuse and worse functional disability.   
QOL was strongly associated with catastrophizing. In child and adolescent chronic pain samples, QOL 
is often measured with the PedsQL [18,52,64,71,72,74,76,112], which assesses physical, emotional, social, and 
school domains [114]. Thus, the strong association between catastrophizing and QOL may be driven, in part, by 
the physical and emotional domains, which overlap with our other outcomes of interest (i.e., anxiety, 
depression, physical functioning) that demonstrated moderate-strong associations with catastrophizing. 
However, the PedsQL also assesses social and school functioning, domains of the pediatric pain experience that 
have received less attention in this literature. Children/adolescents with chronic pain frequently struggle with 
peer relations and academic achievement [31,82], and there is some research suggesting that catastrophizing 
contributes to poorer functioning in these domains [78]. Pain expressions and behaviors might tie these intra- 
and inter-personal factors together. As discussed above, although such behaviors may elicit emotional and 
functional support from others, they can also occasion more punitive responses, such as ignoring or expressions 
of anger or irritation [10], and are associated with interpersonal problems [61]. Although the current findings 
support the notion that pain catastrophizing and general QOL are strongly related in children with pain, future 
research should take a more nuanced approach, separating the construct into individual domains to elucidate 
their unique associations with pain catastrophizing.  
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Catastrophizing and pain intensity were moderately associated. This relationship was the most modest 
and varied (r= -.25 to .58) among those examined in our meta-analysis. Several physiological and neural 
explanations have been proposed to explain the link between catastrophizing and pain intensity; these include 
exaggerated muscle responses at the site of injury [86], altered hypothalamic-pituitary-adrenal axis activity 
[22,51], and lack of activation in brain regions responsible for top-down inhibitory control [92]. Although these 
studies suggest that pain catastrophizing is related to greater activity in brain regions involved in affective 
processing of pain, attention to pain, and pain behaviors, all were conducted in samples of adults with chronic 
pain. Whether and how such explanations apply to children remains an open question. Erpelding and colleagues 
[26] found that, among children with complex regional pain syndrome, pain catastrophizing was correlated with 
increased gray matter and activation in brain regions involved in motor function, sensorimotor integration, and 
anxiety-driven exacerbations of pain – these findings suggest that pain catastrophizing may predispose children 
and adolescents to develop chronic pain, experience greater pain intensity when they do have pain, and engage 
in particular behavioral and emotional responses to that pain. Additional studies are needed to better understand 
the extent to which catastrophizing is a cause and/or consequence of increased pain in children, as well as the 
neurophysiological underpinnings of these relationships.  
The varying effect sizes – magnitude and direction – observed in the current meta-analysis suggest a 
complex relationship between catastrophizing and pain in children that is moderated by other factors. We 
examined several candidate moderators that were suggested by theory and prior studies, however, none 
significantly moderated the relationships examined herein. Though evidence suggests that the pain experience 
differs for boys and girls of varying ages [7,28], the samples included in our analyses were comprised mostly of 
adolescent girls. Additionally, because the majority (83%) of included samples reported moderate (NRS=4) to 
severe (NRS=7) average pain intensity, our moderation analyses of gender, age, and pain intensity may have 
lacked adequate power. Future, high-powered studies are needed to better understand whether and how these 
factors impact the relationship between catastrophizing and pain outcomes in children.  
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Pain duration and pain diagnosis were also not supported as moderators, which suggests that the 
catastrophizing-pain nexus is not altered by the length of time or the specific pain diagnosis a child/adolescent 
has been experiencing. However, it bears noting that the number of studies included in specific pain diagnoses 
subgroups was low (all Ns < 6), thus reducing confidence in the reliability of the null finding. Lastly, pain 
catastrophizing measure did not explain significant heterogeneity in the observed relationships. Nevertheless, 
both Q and I2 values were substantially reduced within categorical moderation subgroups for catastrophizing 
measure and pain diagnosis, indicating a reduction of variability in effect size heterogeneity between studies 
[49].   
Findings from this meta-analysis have implications for treatment. Evidence supports the efficacy of 
several psychological interventions for reducing pain catastrophizing in pediatric samples – these include CBT 
for chronic pain [29,70], relaxation training [29], and Acceptance and Commitment Therapy [29,123]. These 
therapies often educate patients about pain catastrophizing, and some target self-reported catastrophic thoughts 
directly (i.e., through cognitive restructuring) or indirectly (i.e., through experiential exercises). Despite their 
wide use, much remains to be known about the effectiveness of such approaches – individually and/or 
collectively – as well their durability and mechanisms of action. Answers to these questions would provide 
insights for the further refinement of existing treatments and the formulation of new treatments to target 
catastrophic thinking and improve the functioning of children with pain. Results of the current meta-analysis 
suggest that such improvement may be especially achieved in the domains of anxiety and depression, as well as 
overall QOL.  
Several limitations should be acknowledged. The majority of studies used clinical data, which 
introduces several forms of error, including selection bias and unsystematic administration of measures [93]. 
Additionally, clinical data sets are often used repeatedly for various publications, a detail that is not specifically 
and consistently disclosed, making it difficult to guarantee samples and corresponding effect sizes are unique. 
Furthermore, the variability in outcome measures used to assess a particular outcome (e.g. physical functioning) 
may influence effect sizes. Another limitation, common in meta-analyses, is the file drawer problem [80]. 
Though the results of fail-safe analyses instill confidence in the meta-analytic findings for all of our primary 
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outcome variables, we cannot rule out the existence of unpublished studies that would have changed these 
findings had they been included. This meta-analysis only included a selection of outcomes that may be 
associated with catastrophizing. Unfortunately, other potentially important outcomes, such as school 
performance, are not commonly reported in the pediatric pain literature and thus were not included herein. 
Lastly, all measures were self-report and used similar item-response formats, thus, increasing the possibility that 
common method bias contributed to the observed associations.  
Future studies should aim to elucidate possible moderators of the relationship between catastrophizing 
and pain outcomes, as the current results indicate considerable between-study variability in the nature of this 
relationship. Future research may also investigate the effectiveness of current interventions in reducing 
catastrophic thinking and the magnitude of these effects over time. These findings would serve to enhance the 
individualization of treatments for chronic pain in children. The role of parents is important to examine as well. 
Many studies have reported significant relationships between parental catastrophizing and child pain outcomes 
[37,67,74], but these relationships have yet to be meta-analytically quantified.  
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Table 1. Summary of Study Characteristics Across Independent 
Samples (k=38) 
Sample Characteristics k/N % 
Median year (range) 2013 (1998 - 2017) 
 Mean sample size (SD) 145 (159.4) 
 Median sample size (Range) 77 (6 - 725) 
 Mean Age (SD) 14.4 (1.50) 
 Gender (% Female) 
 
72 
Race (% White) 
 
80 
Country of Study 
  United States 24 63.2 
Belgium 2 5.3 
Germany 3 7.9 
Denmark 4 10.5 
Netherlands 1 2.6 
United Kingdom 3 7.9 
Sweden 1 2.6 
Catastrophizing Measure Used 
  PCS-C 23 60.5 
PCS (adult) 5 13.2 
PRI 1 2.6 
CSQ-C 1 2.6 
PCQ 8 21.1 
PRCQ 1 2.6 
Outcomes Measured 
  Pain Intensity 35 92.1 
Physical Functioning 30 78.9 
Anxiety 15 39.5 
Depression 19 50.0 
Quality of Life 2 5.3 
Setting 
  Inpatient 2 5.3 
Outpatient 36 94.7 
Pain Diagnosis 
  Mixed Chronic Pain 21 55.3 
Sickle Cell 2 5.3 
Abdominal Pain 4 10.5 
Headache 2 5.3 
Fibromyalgia 3 7.9 
Arthritis 4 10.5 
Lupus 1 2.6 
Chronic Low Back Pain 1 2.6 
Abbreviations: PCS = Pain Catastrophizing Scale (adult version), PCS-C = 
Pain Catastrophizing Scale for Children, PRCQ-C = Pain-Related Cognitions 
Questionnaire for Children, PCQ = Pain Coping Questionnaire, CSQ-C = 
Coping Strategies Questionnaire for Children, PRI = Pain Response 
Inventory 
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Table 2. Ratings of Study Quality 
 
Study 
Was the 
independent 
variable assessed 
with a validated 
measure? 
Was reliability 
information for the 
independent variable 
reported and above 
α=.70 for the current 
sample? 
Was the 
dependent 
variable clearly 
defined, using a 
measure that had 
been validated 
before? 
Was reliability 
information for the 
dependent variable 
reported and α=.70 
for the current 
sample? 
Was the 
study 
part of a 
RCT? 
Were both 
variables 
continuous? 
Was the 
data 
collected 
as part of 
a research 
study 
Was the 
participation 
rate of eligible 
individuals at 
least 50% 
Single 
pain 
diagnosis 
pain 
sample? 
Power 
analysis? 
Quality 
Score 
Benore et al. (2015) Yes No Yes No No Yes No No No No 3 
Bhandari et al. (2016) Yes No Yes No No Yes No NR No No 3 
Cousins et al. (2015) Yes Yes Yes Yes No Yes Yes Yes No Yes 8 
Crombez et al. (2003) Yes Yes Yes Yes No Yes Yes Yes No No 7 
Cunningham et al. (2014) Yes Yes Yes Yes No Yes Yes Yes Yes No 8 
Engel et al. (2013) Yes Yes Yes Yes No Yes Yes NR No No 6 
Flink et al. (2016) Yes No Yes No No Yes Yes Yes No No 5 
Guite et al (2011b) Yes Yes Yes Yes No Yes Yes NR No No 6 
Guite et al (2011a) Yes Yes Yes Yes No Yes No NR No No 5 
Heathcote et al. (epub) Yes Yes Yes Yes No Yes Yes Yes No No 7 
Hermann et al. (2007) Yes Yes Yes No No Yes No NR No No 4 
Jones et al. (2016) Yes Yes Yes Yes No Yes No NR Yes No 6 
Kashikar-Zuck et al. (2013) Yes No Yes No Yes Yes Yes No Yes No 6 
Keogh & Eccleston (2006) Yes No Yes No No Yes No NR No No 3 
Kroner-Herwig & Maas 
(2013) Yes No Yes No No Yes Yes NR Yes No 5 
Libby & Glenwick (2010) Yes Yes Yes Yes No Yes Yes No Yes Yes 8 
Lomholt et al. (2013) Yes Yes Yes Yes No Yes Yes Yes Yes No 8 
Lomholt et al. (2015) Yes Yes Yes Yes No Yes Yes No Yes No 7 
Lynch et al. (2007) Yes Yes Yes Yes No Yes No NR No No 5 
Lynch et al. (2006) Yes Yes Yes No No Yes No NR Yes No 5 
Lynch-Jordan et al. (2013) Yes Yes Yes Yes No Yes No NR No No 5 
Mano et al. (2012) Yes Yes Yes Yes No Yes No NR No No 5 
Mano et al. (2013) Yes No Yes No Yes Yes Yes No No No 5 
Miller et al. (2016) Yes Yes Yes Yes No Yes No NR No No 5 
Pielech et al. (2014) Yes Yes Yes Yes No Yes No NR No No 5 
Sil et al. (2016a) Yes Yes Yes Yes No Yes Yes Yes Yes No 8 
Sil et al. (2016b) Yes Yes Yes Yes No Yes Yes Yes Yes Yes 9 
Simons et al. (2015a) Yes No Yes No No Yes Yes Yes Yes No 6 
Simons et al. (2015b) Yes Yes Yes Yes No Yes Yes Yes No No 7 
Thastum et al. (2005) Yes Yes Yes Yes No Yes Yes Yes Yes No 8 
Thastum et al. (1999) Yes Yes Yes No No Yes Yes NR Yes Yes 7 
Tran et al. (2017) Yes No Yes No No Yes Yes N Yes No 5 
Tran et al. (2015) Yes Yes Yes Yes No Yes No NR No No 5 
van Tilburg et al. (2015) Yes No Yes No Yes Yes Yes Yes Yes No 7 
Verbunt et al. (2015) Yes No Yes No No Yes Yes N No No 4 
Vervoort et al. (2009) Yes Yes Yes Yes No Yes Yes Yes No No 7 
Vervoort et al. (2008) Yes Yes Yes Yes No Yes Yes Yes No No 7 
Warschburger et al (2014) Yes Yes Yes Yes No Yes Yes No Yes No 7 
Chow et al. (2016) Same sample as Simons, 2015 
Vervoort et al. (2006) Same sample as Crombez 2003 
  
NR=Not reported 
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Table 3. Description of Included Studies 
Study Year Sample Size 
Percent 
Female 
Percent 
White 
Mean 
Age 
Chronic Pain 
Diagnosis 
Catastrophizing 
Questionnaire 
Outcome 
Association 
Measure Used to 
Assess Outcome 
ES 
original 
ES 
corrected 
Benore et al. [6] 2015 119 77% 95% 15.1 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.18 0.18 
Physical 
Functioning BAPQ-PFss 0.41 0.37 
Physical 
Functioning PedsQL-PFss 0.46 0.50 
Anxiety BAPQ - GAss 0.57 0.65 
Anxiety BAPQ - PSAss 0.77 1.02 
Depression BAPQ - Dss 0.60 0.69 
Bhandari et al. 
[3] 2016 352 75% 68% 13.9 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.26 0.26 
Physical 
Functioning PROMIS - mobility 0.32 0.33 
Anxiety PROMIS - anxiety 0.64 0.76 
Depression 
PROMIS - 
depression 0.59 0.68 
Chow et al. [10] 2016 195 76% 93% 13.8 
Mixed Pain 
Sample PCS-C Anxiety RCMAS 0.54 0.60 
Depression CDI 0.45 0.48 
Cousins et al. 
[13] 2015 58 79% 60% 14.6 
Mixed Pain 
Sample PCS-C Pain Intensity VAS  0.44 0.47 
Physical 
Functioning FDI 0.47 0.51 
Quality of Life PedsQL -0.60 -0.69 
Crombez et al. 
[14] 2003 43 54% 100% 11.83 
Mixed Pain 
Sample PCS-C Pain Intensity VAS  0.49 0.54 
Physical 
Functioning FDI 0.50 0.55 
Cunningham et 
al. [15] 2014 75 77% 83% 13.84 Abdominal Pain PCS-C Pain Intensity NRS (0-10) 0.44 0.47 
Physical 
Functioning FDI 0.53 0.59 
Engel et al. [20] 2013 80 43% 77% 14.35 
Mixed Pain 
Sample PCS Pain Intensity NRS (0-10) -0.25 -0.26 
Physical 
Functioning FDI 0.19 0.19 
Flink et al. [25] 2016 6 83% 100% 18.33 
Mixed Pain 
Sample PCS-C 
Physical 
Functioning FDI 0.72 0.91 
Anxiety HADS-A 0.57 0.65 
Depression HADS-D 0.01 0.01 
Guite et al.(a) 
[29] 2011 138 84% 87% 15.6 
Mixed Pain 
Sample PCS Pain Intensity VAS  0.34 0.35 
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Physical 
Functioning FDI 0.38 0.40 
Guite et al.(b) 
[28] 2011 259 78% 93% 15.1 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.22 0.22 
Physical 
Functioning FDI 0.20 0.20 
Heathcote et al. 
[34] 2017 66 83% - 13.97 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.28 0.29 
Physical 
Functioning FDI 0.31 0.32 
Anxiety RCADS-GADss 0.46 0.49 
Depression RCADS-MDDss 0.56 0.63 
Hermann et al.* 
[35] 2007 71 - - - 
Mixed Pain 
Sample PRCQ Pain Intensity CSI 0.30 0.31 
69 - - - Anxiety CAT-II 0.60 0.69 
106 - - - Depression DTC-DMss 0.30 0.31 
Depression DTC-ABss 0.13 0.13 
Depression DTC-Ess 0.21 0.21 
Jones et al. [44] 2016 60 88% 50% 16.1 Lupus PCS Pain Intensity VAS  0.35 0.37 
Anxiety SCARED 0.52 0.58 
Depression CDI 0.58 0.66 
Quality of Life PedsQL -0.59 -0.68 
Kashikar-Zuck et 
al. [48] 2013 100 93% 90% 15.02 
Juvenile 
Fibromyalgia PCQ 
Physical 
Functioning FDI 0.15 0.15 
Depression CDI 0.33 0.34 
Keogh & 
Eccleston** [50] 2006 
46 
(male) 0% - - 
Mixed Pain 
Sample PCQ Pain Intensity NRS (0-10) 0.44 0.47 
Physical 
Functioning FDI 0.32 0.33 
Anxiety SCAS 0.53 0.59 
Depression CDI 0.56 0.63 
115 
(female) 100% - - Pain Intensity NRS (0-10) 0.21 0.22 
Physical 
Functioning FDI 0.33 0.34 
Anxiety SCAS 0.50 0.55 
Depression CDI 0.58 0.66 
Kröner-Herwig 
& Maas [51] 2013 60 55% NR 12.6 Headache PCS-C Pain Intensity NRS (0-10) 0.25 0.26 
Libby & 
Glenwick [54] 2010 57 93% 2% 15.5 
Juvenile 
Fibromyalgia CSQ-C Pain Intensity VAS  0.33 0.34 
Depression CDI 0.46 0.50 
Quality of Life PedsQL -0.67 -0.81 
Lomholt et al. (a) 2013 91 77% NR 12.7 Arthritis PCQ Pain Intensity FPS-R 0.39 0.41 
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[59] 
Physical 
Functioning CHAQ 0.22 0.22 
Lomholt et al. (b) 
[58] 2015 19 79% NR 11.72 Arthritis PCQ Pain Intensity FPS-R 0.30 0.31 
Physical 
Functioning FDI 0.45 0.48 
Anxiety BAI 0.38 0.40 
Depression BDI 0.72 0.91 
Quality of Life PedsQL -0.53 -0.59 
Lynch et al.** 
[62] 2007 70 0% - - 
Mixed Pain 
Sample PCQ Pain Intensity VAS  0.20 0.20 
202 100% - - Pain Intensity VAS  0.11 0.11 
Lynch et al. [63] 2006 65 80% 91% 14.9 Chronic Back Pain PCQ Pain Intensity VAS  0.25 0.26 
Physical 
Functioning FDI 0.57 0.65 
Lynch-Jordan et 
al. [64] 2013 240 77% 89% 14.76 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.38 0.40 
Physical 
Functioning FDI 0.51 0.56 
Depression CDI 0.58 0.66 
Quality of Life PedsQL -0.24 -0.24 
Mano et al. [66] 2012 349 69% 77% 14.2 
Mixed Pain 
Sample PCS-C Anxiety SCARED 0.56 0.63 
Quality of Life PedsQL -0.50 -0.55 
Mano et al. [67] 2013 6 83% 67% 13.75 
Mixed Pain 
Sample PCS 
Physical 
Functioning CALQ -0.38 -0.40 
Anxiety STAI-C Trait Scale 0.54 0.60 
Anxiety STAI-C State Scale 0.68 0.83 
Miller et al. [68] 2016 139 72% 92% 15 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.58 0.66 
Physical 
Functioning FDI 0.34 0.35 
Pielech et al. [74] 2014 697 77% 92% 13.9 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.26 0.27 
Physical 
Functioning FDI 0.32 0.33 
Anxiety RCMAS 0.45 0.48 
Depression CDI 0.35 0.37 
Sil et al. (a) [82] 2016 40 NR NR NR Sickle Cell PCS-C Pain Intensity NRS (0-10) 0.05 0.05 
Physical 
Functioning FDI 0.20 0.20 
Depression CDI 0.04 0.04 
Quality of Life PedsQL -0.43 -0.46 
Sil et al. (b) [83] 2016 100 61% 0% 13.54 Sickle Cell PCS-C Pain Intensity NRS (0-10) 0.26 0.27 
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Physical 
Functioning FDI 0.31 0.32 
Simons et al. (a) 
[85] 2015 206 73% 90% 13.6 Headache PCS-C Pain Intensity NRS (0-10) 0.21 0.22 
Physical 
Functioning FDI 0.46 0.49 
Simons et al. (b) 
[86] 2015 321 75% 90% 13.73 
Mixed Pain 
Sample PCS-C 
Physical 
Functioning FDI 0.40 0.42 
Thastum et al. 
[92] 2005 56 80% - 11.4 Arthritis PCQ Pain Intensity VAS 0.33 0.34 
Thastum et al. 
[93] 1998 16 - - - Arthritis PCQ Pain Intensity VAS -0.02 -0.02 
Tran et al. [95] 2015 725 69% 75% - 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.38 0.40 
Physical 
Functioning CALQ 0.48 0.52 
Anxiety SCARED 0.53 0.59 
Quality of Life PedsQL -0.50 -0.55 
Tran et al. [94] 2017 13 100% 92% 15.94 
Juvenile 
Fibromyalgia PCS-C Pain Intensity VAS  0.57 0.65 
Physical 
Functioning FDI 0.50 0.55 
Depression CDI 0.44 0.47 
van Tilburg et al.t 
[96] 2015 189 49% 88% 13.76 IBD PRI 
Physical 
Functioning FDI 0.55 0.62 
Depression CDI 0.54 0.61 
200 73% 96% 11.2 Abdominal Pain 
Physical 
Functioning FDI 0.42 0.45 
Depression CDI 0.52 0.58 
Verbunt et al. 
[98] 2015 71 91% - 17 
Mixed Pain 
Sample PCS-C Pain Intensity VAS  0.41 0.44 
Physical 
Functioning FDI 0.52 0.58 
Depression CDI 0.60 0.69 
Vervoort et al. 
[101] 2006 43 54% 100% 11.8 
Mixed Pain 
Sample PCS-C Anxiety STAI-C Trait Scale 0.57 0.65 
Vervoort et al. 
[102] 2009 38 76% 100% 15.74 
Mixed Pain 
Sample PCS-C Pain Intensity NRS (0-10) 0.10 0.10 
Vervoort et al. 
[99] 2008 61 57% 96% 13.33 
Mixed Pain 
Sample PCS Pain Intensity VAS  0.32 0.33 
Warschburger et 
al. [103] 2014 170 64% NR 11.7 Abdominal Pain PRCQ-R Pain Intensity FPS-R 0.27 0.28 
Quality of Life KINDL-R -0.35 -0.37 
*Study reported different Ns for each measure; **Study reported separate correlations for boys and girls; t Study reported separate correlations by diagnosis subsample 
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Abbreviations: IBD = Inflammatory Bowel Disease, PCS = Pain Catastrophizing Scale (adult version), PCS-C = Pain Catastrophizing Scale for Children, PRCQ-C = Pain-Related 
Cognitions Questionnaire for Children, PCQ = Pain Coping Questionnaire, CSQ-C = Coping Strategies Questionnaire for Children, PRI = Pain Response Inventory, BAPQ - Dss = 
Bath Adolescent Pain Questionnaire - Depression subscale, BAPQ - GAss = Bath Adolescent Pain Questionnaire - General anxiety subscale, BAPQ - PSAss = Bath Adolescent 
Pain Questionnaire - Pain-specific anxiety subscale, BAPQ-PFss = Bath Adolescent Pain Questionnaire - Physical functioning subscale, CALQ = Child Activity Limitations 
Questionnaire, CAT-II = Children's Anxiety Test - II, CDI = Children's Depression Inventory, CHQ-CF87 - MHss = Child Health Questionnaire - Mental Health subscale, CSI = 
Children's Somatization Inventory, DTC-ABss = Depression Test for Children - Agitated Behavior subscale, DTC-DMss = Depression Test for Children - Dysphoric Mood 
subscale, DTC-Ess = Depression Test for Children - Exhaustion/somatic complaints subscale, FDI = Functional Disability Inventory, HADS-A = Hospital Anxiety and Depression 
Scale - Anxiety subscale, HADS-D = Hospital Anxiety and Depression Scale - Depression subscale, NRS = Numeric Rating Scale, FPS-R = Faces of Pain Scale - Revised, CHAQ 
= Childhood Health Assessment Questionnaire, PedsQL = Pediatric Quality of Life, PedsQL - EFss = Pediatric Quality of Life - Emotional Functioning subscale, PedsQL-PFss = 
Pediatric Quality of Life - Physical Functioning subscale, BAI = Beck Anxiety Inventory, BDI = Beck Depression Inventory, PROMIS - anxiety = PROMIS Anxiety Question 
Bank, PROMIS - depression = PROMIS Depression Question Bank, PROMIS - mobility = PROMIS Mobility Question Bank, RCADS-GADss = Revised Child Anxiety and 
Depression Scale - Generalized Anxiety Disorder subscale, RCADS-MDDss = Revised Child Anxiety and Depression Scale - Major Depressive Disorder subscale, RCMAS = 
Revised Children's Manifest Anxiety Scale, SCARED = Screen for Child Anxiety-Related Disorders, SCAS = Spence Children's Anxiety Scale, STAI-C State Scale = State-Trait 
Anxiety Inventory for Children-State scale, STAI-C Trait Scale = State-Trait Anxiety Inventory for Children-Trait scale, VAS = Visual Analog Scale, PRCQ-R = Pain Related 
Coping Questionnaire - Revised  
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Table 4. Mean Effect Sizes 
       Association K N ES (r) SE 95% C.I. Z Q I2 
Random-effects model 
        Pain Intensity 35 4661 0.29** 0.03 [0.24, 0.34] 11.37 85.12** 60.06 
Physical Disability 30 4622 0.39** 0.03 [0.35, 0.43] 15.26 72.33** 59.91 
Anxiety 15 2867 0.55** 0.03 [0.50, 0.59] 18.96 28.04** 50.07 
Depression 19 2691 0.49** 0.04 [0.43, 0.55] 12.58 66.96** 73.12 
Quality of Life 10 1724 -0.48** 0.06 [-0.56, -0.39] -9.32 30.31** 70.31 
*p<.05, **p<.01 
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Table 5. Continuous Moderator Analyses 
  Association K (N) β (SE) 95% CI Z 
Pain Intensity 
    Gender 32 (4534) 0.04 (0.14) [-0.23, 0.31] 0.29 
Age 27 (3376) -0.002 (0.02) [-0.05, 0.04] -0.10 
Pain Intensity 30 (4246) -0.0002 (0.02) [-0.05, 0.04] -0.01 
Pain Duration 20 (3082) 0.001 (0.002) [-0.002. 0.005] 0.73 
Physical Disability 
    Gender 29 (4582) -0.07 (0.16) [-0.39, 0.25] -0.42 
Age 26 (3696) -0.004 (0.02) [-0.05, 0.04] -0.16 
Pain Intensity 25 (3900) 0.03 (0.02) [-0.01, 0.08] 1.47 
Pain Duration 17 (3228) 0.001(0.003) [-0.005, 0.006] 0.28 
Anxiety 
    Gender 14 (2798) -0.06 (0.19) [-0.43, 0.32] -0.29 
Age 11 (1912) 0.03 (0.04) [-0.05, 0.12] 0.74 
Pain Intensity 11 (2591) 0.02 (0.04) [-0.05, 0.10] 0.65 
Pain Duration 11 (2434) -0.002 (0.003) [-0.008, 0.003] -0.84 
Depression 
    Gender 17 (2545) -0.08 (0.18) [-0.43, 0.27] -0.46 
Age 15 (2384) -0.001 (0.03) [-0.05, 0.05] -0.02 
Pain Intensity 14 (1995) -.01 (0.04) [-0.10, 0.07] -0.33 
Pain Duration 11 (1728) .01 (0.003) [-0.0003, 0.01] 1.87 
Quality of Life 
    Gender 9 (1684) -1.07 (0.62) [-2.29, 0.14] -1.73 
Age 8 (959) -0.06 (0.15) [-0.15, 0.04] -1.20 
Pain Intensity 9 (1718) 0.04 (0.04) [-0.04, 0.13] 0.96 
Pain Duration 6 (1451) -0.002 (0.006) [-0.01, 0.01] -0.27 
*p<.05, **p<.01 
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Table 6. Categorical Moderator Analyses 
     Chronic Pain Diagnosis 
       Association                 
  I2 k (N)   r 95% CI z(SE) Q(w) Q(b) 
CAT - PI 
 
30 (4213) 0.30 [0.24, 0.35] 9.90**(0.03) 30.19 1.97 
         
 
27.59 
 
Mixed Pain (k=20) 0.28 [0.22, 0.35] 7.99**(0.04) 26.24 
 
         
 
58.33 
 
Arthritis (k=2) 0.34 [0.15, 0.50] 3.48**(0.10) 2.40 
 
         
 
0.00 
 
Sickle Cell (k=2) 0.18 [-0.06, 0.41] 1.45(0.13) 0.68 
 
         
 
0.00 
 
Abdominal Pain (k=2) 0.35 [0.14, 0.52] 3.22**(0.11) 0.75 
 
         
 
0.00 
 
Musculoskeletal (k=2) 0.37 [0.16, 0.54] 3.40**(0.11) 0.12 
 
         
         
         
         CAT - PF 
 
27 (4251) 0.39 [0.35, 0.42] 17.18**(0.02) 22.65 7.74 
         
 
0.00 
 
Mixed Pain (k=20) 0.37 [0.33, 0.42] 13.68**(0.03) 18.59 
 
         
 
0.00 
 
Arthritis (k=5) 0.30 [0.09, 0.48] 2.81**(0.11) 1.43 
 
         
 
0.00 
 
Sickle Cell (k=2) 0.27 [0.08, 0.45] 2.75**(0.10) 0.29 
 
         
 
28.06 
 
Abdominal Pain (k=2) 0.50 [0.40, 0.58] 8.48**(0.06) 1.39 
 
         
 
0.00 
 
Musculoskeletal (k=2) 0.44 [0.29,  0.56] 5.31**(0.09) 0.95 
 
         CAT - DEP 
 
16 (2520) 0.50 [0.44, 0.55] 14.36**(0.04) 14.14 2.52 
         
 
28.68 
 
Mixed Pain (k=10) 0.50 [0.43, 0.56] 11.93**(0.05) 12.62 
 
         
 
0.00 
 
Abdominal Pain  (k=2) 0.53 [0.39, 0.65] 6.42**(0.09) 0.03 
 
         
 
2.91 
 
Arthritis (k=2) 0.62 [0.31, 0.82] 3.47**(0.21) 1.03 
 
         
  0.00   Fibromyalgia  (k=2) 0.39 [0.18, 0.56] 3.61**(0.11) 0.46   
*p<.05, **p<.01 
       CAT = catastrophizing, PI = pain intensity, PD = physical functioning, DEP = depression, ANX = anxiety 
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Table 7. Categorical Moderator Analyses 
     Catastrophizing Measure 
       Association                 
  I2 k (N)   r 95% CI z(SE) Q(w) Q(b) 
CAT - PI 
 
33 (4434) 0.29 [0.24, 0.35] 
10.89** 
(0.03) 32.79 3.93 
         
 
0.00 
 
PCS-C (k=21) 0.33 [0.26, 0.38] 9.96**(0.03) 17.95 
 
         
 
0.00 
 
PCQ  (k=9) 0.25 [0.15, 0.35] 4.48**(0.06) 4.80 
 
         
 
80.08 
 
PCS  (k=3) 0.16 [-0.01, 0.33] 1.80(0.09) 10.04 
 
         CAT - PF 
 
30 (4622) 0.39 [0.35, 0.43] 17.00**(0.02) 28.58 5.32 
         
 
0.47 
 
PCS-C (k=20) 0.40 [0.35,  0.45] 14.39**(0.03) 19.09 
 
         
 
7.41 
 
PRI (k=2) 0.49 [0.36, 0.60] 6.81**(0.08) 1.08 
 
         
 
30.17 
 
PCQ  (k=6) 0.32 [0.21, 0.42] 5.41**(0.06) 7.16 
 
         
 
20.00 
 
PCS  (k=2) 0.30 [0.21, 0.45] 3.42**(0.09) 1.25 
 
         CAT - ANX 
 
14 (2807) 0.55 [0.50 , 0.59] 18.53**(0.03) 9.52 0.8 
         
 
0.00 
 
PCS-C (k=11) 0.56 [0.51, 0.60] 17.62**(0.04) 9.16 
 
         
 
0.00 
 
PCQ  (k=2) 0.49 [0.42, 0.62] 5.82**(0.09) 0.36 
 
         CAT - DEP 
 
17 (2574) 0.49 [0.42, 0.55] 9.28**(0.05) 17.62 0.71 
         
 
29.28 
 
PCS-C (k=11) 0.47 [0.38, 0.55] 9.28**(0.05) 14.14 
 
         
 
0.00 
 
PRI  (k=2) 0.53 [0.35, 0.67] 5.31**(0.11) 0.02 
 
         
  13.29   PCQ  (k=4) 0.52 [0.37, 0.65] 5.91**(0.10) 3.46   
*p<.05, **p<.01 
 
          
 CAT = catastrophizing, PI = pain intensity, PF = physical functioning, DEP = depression, ANX = anxiety 
 AC
EP
TE
D
Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            201
Table 8. Study Quality Moderator Analysis 
     Association                 
  I2 k (N)   r 95% CI z(SE) Q(w) Q(b) 
CAT - PI 
 
34 (4618) 
 
0.29 [0.24, 0.34] 10.92** (0.03) 34.12 0.91 
         
 
0.00 
 
QR ≤ 5  (k=16) 0.31 [0.26, 0.37] 8.64**(0.04) 13.87 
 
         
 
16.05 
 
QR ≥ 6  (k=18) 0.26 [0.19, 0.34] 6.74**(0.04) 20.25 
 
         CAT - PF 
 
29 (4579) 
 
0.39 [0.34, 0.43] 15.34**(0.03) 27.85 0.96 
         
 
0.00 
 
QR ≤ 5  (k=14) 0.41 [0.36, 0.47] 11.36**(0.04) 10.32 
 
         
 
20.14 
 
QR ≥ 6  (k=15) 0.36 [0.31, 0.42] 10.35**(0.04) 17.53 
 
         CAT - ANX 
 
15(2867) 
 
0.55 [0.55, 0.65] 19.01**(0.03) 9.95 0.66 
         
 
0.00 
 
QR ≤ 5  (k=10) 0.56 [0.56, 0.60] 17.09**(0.04) 8.96 
 
         
 
0.00 
 
QR ≥ 6  (k=5) 0.52 [0.44, 0.60] 8.58**(0.07) 0.99 
 
         CAT - DEP 
 
19(2691) 
 
0.49 [0.46, 0.55] 13.47**(0.04) 19.84 0.30 
         
 
11.42 
 
QR ≤ 5  (k=10) 0.51 [0.45, 0.58] 10.19**(0.06) 10.16 
 
         
 
0.00 
 
QR ≥ 6  (k=19) 0.48 [0.40, 0.56] 8.82**(0.06) 9.68 
 
         CAT - QOL 
 
10 (1724) 
 
-0.48 [-0.62, -0.39] -9.50*(0.05) 7.84 1.37 
         
 
5.96 
 
QR ≤ 5  (k=4) -0.42 [-0.61, -0 .29] -5.82*(0.08) 3.19 
 
         
  0.00   QR ≥ 6  (k=6) -0.52 [-0.73, -0.41] -7.60**(0.08) 4.65   
*p<.05, **p<.01 
 
     
 CAT = catastrophizing, PI = pain intensity, PF = physical functioning, DEP = depression, ANX = anxiety, QOL = 
quality of life 
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Table 9. Comparison of Mean Effect Sizes 
      Association                 
Random-effects model K N ES (r) SE 95% C.I. Z Q I2 
Full Sample 
        Pain Intensity 35 4661 0.29** 0.03 [0.24, 0.34] 11.37 85.12** 60.06 
Physical Disability 30 4622 0.39** 0.03 [0.35, 0.43] 15.26 72.33** 59.91 
Anxiety 15 2867 0.55** 0.03 [0.50, 0.59] 18.96 28.04** 50.07 
Depression 19 2691 0.49** 0.04 [0.43, 0.55] 12.58 66.96** 73.12 
Quality of Life 10 1724 -0.48** 0.06 [-0.56, -0.39] -9.32 30.31** 70.31 
         18 and under Sample 
        Pain Intensity 30 4369 0.30** 0.02 [0.27, 0.33] 12.88 55.86** 48.08 
Physical Disability 26 4422 0.39** 0.03 [0.34, 0.43] 14.65 65.28** 61.70 
Anxiety 12 2606 0.55** 0.04 [0.49, 0.60] 16.07 27.99** 60.70 
Depression 15 2359 0.49** 0.05 [0.41, 0.56] 10.62 62.77** 77.70 
Quality of Life 9 1664 -0.47** 0.06 [-0.55, -0.37] -8.56 28.53** 71.96 
         Exclusively Chronic Pain (3+ months) 
      Pain Intensity 27 2678 0.27** 0.03 [0.21, 0.34] 8.17 67.46** 61.46 
Physical Disability 22 2374 0.36** 0.04 [0.30, 0.42] 10.57 51.89** 59.53 
Anxiety 11 1207 0.58** 0.04 [0.53, 0.62] 18.29 12.44** 19.61 
Depression 17 1799 0.51** 0.04 [0.45, 0.57] 13.11 41.67** 61.60 
Quality of Life 9 999 -0.48** 0.07 [-0.58, -0.36] -7.36 27.74** 71.16 
*p<.05, **p<.01 
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Figure 1.  
PRISMA Flow Diagram 
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Figure 3.  
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Figure 4.  
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Figure 5.  
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Figure 6.  
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